Leukemia Cell Recognition Presents New Possibility for Therapy

Share this content:

the Cancer Therapy Advisor take:

When cancer cells that originate from blood cells accumulate in the blood or bone marrow, the condition is called leukemia, which is currently treated with chemotherapy and stem cell transplants. This eradicates cancer cells and restores healthy blood cells.


According to a study published in Journal of Experimental Medicine online, methyl-lysophosphatidic acid (mLPA) is a newly discovered class of lipids, and these lipids accumulate in leukemia cells. In addition, co-lead researchers Lucia Mori and Gennaro De Libero and their research team at A*STAR’s Singapore Immunology Network identified mLPA-specific T-cells, which are a group of immune cells that can recognize mLPA in leukemia cells. This detection stimulates an immune response, which activates T cells that kill the leukemia cells and hinder cancer progression.


Prior to the study, it was known that only proteins in cancer cells could activate T cells. While proteins differ in individuals, lipids are the same in all patients. Mori said this discovery leads to a new path for future leukemia studies as well as sheds light on ongoing studies on proteins in cancer cells.


Since current treatments may undergo failure due to residual leukemia cells surviving and re-growing after stem cell transplants, this new potential therapy may prove as an effective complement.

Prediagnostic Use of Warfarin Has No Effect on Cancer-Specific Mortality for Patients with Breast, C
Leukemia Cell Recognition Presents New Possibility for Therapy

Scientists at A*STAR's Singapore Immunology Network (SIgN) have discovered a new class of lipids in the leukemia cells that are detected by a unique group of immune cells. By recognizing the lipids, the immune cells stimulate an immune response to destroy the leukemia cells and suppress their growth. The newly identified mode of cancer cell recognition by the immune system opens up new possibilities for leukemia immunotherapy.

Leukemia is characterized by the accumulation of cancer cells originating from blood cells, in the blood or bone marrow. Current treatments for leukemia largely involve chemotherapy to eradicate all cancer cells, followed by stem cell transplants to restore healthy blood cells in the patients.

READ FULL ARTICLE From Science Daily

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs